Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
7d
HealthDay on MSNClinical Guidelines Updated for Evaluation, Management, Treatment of CKDIn a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
17d
MedPage Today on MSNUpdated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 InhibitorsUse of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization's updated clinical practice guideline. In a synopsis of the recently ...
An Australian medical technology company, Proteomics International, has published a study demonstrating a new blood test significantly outperforms conventional tests in identifying the risk of ...
Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and management of chronic kidney disease (CKD) in ...
Medscape Medical News, March 19, 2024 Exercise Linked to Lower Kidney Disease Risk in Diabetes Higher ... Guideline Aims to Improve Care The KDIGO updates addressed the "unprecedented pace ...
Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...
Both the Kidney Disease Improving Global Outcomes (KDIGO) and National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines encourage work with an RD. The great ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results